Find the Best in Columbus, Ohio

Roxane Laboratories, Inc. Announces the Launch of Perindopril Erbumine Tablets (redOrbit)

COLUMBUS, Ohio, Nov. 10 /PRNewswire/ — Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Perindopril Erbumine Tablets, 2mg, 4mg and 8mg by the U.S. Food and Drug Administration.

See the rest here:
Roxane Laboratories, Inc. Announces the Launch of Perindopril Erbumine Tablets (redOrbit)

Comments

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!





Powered by Yahoo! Answers